Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Completed NCT03222531

Expanding the Pool in Orthotopic Heart Transplantation

Conditions: Hepatitis C, Heart Transplant, Cardiac Transplant

Sex: All

Ages: 18 Years – 71 Years

Healthy volunteers: No

Phase: PHASE2

Enrollment: 20

Sponsor: Mary E. Keebler, MD

Location: UPMC Pittsburgh Pennsylvania

Summary

This is an open-label, pilot trial to test the safety and efficacy of transplantation of hearts from HCV seropositive non-viremic (HCV Ab+/NAT-) and HCV seropositive viremic (HCV Ab+/NAT+) donors to HCV seronegative recipients on the heart transplant waitlist. Treatment and prophylaxis will be administered, using a transmission-triggered approach for the first scenario (HCV Ab+/NAT- donors, arm 1) and a prophylaxis approach for the later scenario (HCV Ab+/NAT+ donors, arm 2).

Eligibility Criteria

Inclusion criteria (recipients): * End stage heart failure * Age ≥ 18 and \

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT03222531). StuddyBuddy aggregates publicly available trial information.